Mazin Antonious Moufarij is a full time Assistant Professor in the Faculty of Natural and Applied Sciences at Notre Dame University, North Lebanon Campus. He was awarded the Australian Postgraduate Award scholarship to pursue his doctoral medical research in Clinical Pharmacology at the Peter MacCallum Cancer Centre-Australia. His Fellowship training at MD Anderson Cancer Centre-Texas involved an active translational research program on novel therapies in Chronic Lymphocytic Leukemia. His research interests continue to concentrate around the chromosomal basis (Cytogenetics) of Genetic diseases.
Dr. Moufarij won several national and international awards during his doctoral and postdoctoral research training. He returned to Lebanon in 2006 to join the Faculty of Medicine at the University of Balamand and Department of Laboratory medicine at St. George University Medical Center, where he established the Cancer Cytogenetics Unit. He taught at several universities in Lebanon and has been a part-time faculty member at NLC since 2009.
Dr Moufarij, a tobacco control advocate, co-founded the Lebanese coalition for tobacco control and attended numerous workshops and completed several courses at the International Union against Tuberculosis and Lung Disease.

Ph.D. in Clinical Pharmacology, Peter MacCallum Cancer Center, Australia, 2003

Associate of Arts degree in Teaching, Australian Council for private Education & Training, 2001

B. Med. Sc. (Hons), La Trobe University, Melbourne, Australia, 1999

Refereed Journal Articles

Moufarij, M.A. (2006) Cytogenetics: Major insights from microscopic details. Leb. J. of Med. Sci., 14: 4-7.

Moufarij, M.A., Sampath, D., Keating, M.J. and Plunkett, W. (2006) Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal. Blood, 108: 4187-4193.

Moufarij, M.A., Phillips, D.R. and Cullinane, C. (2003) Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines. Mol. Pharmacol., 63: 862-869.

Moufarij, M.A., Phillips, D.R. and Cullinane, C. (2002) Inhibition of repair of cisplatin-induced DNA damage by gemcitabine in 2008 ovarian cancer cells. In “Research Trends in Science and Technology”, Kabbani A. and El-Kassar, A. (Eds), Lebanese American University Press, Beirut, pp161-176.

Moufarij, M.A., Cutts, S.M., Neumann, G.M., Kimura, K-I. and Phillips D.R. (2001) Barminomycin functions as a potent pre-activated analogue of Adriamycin. Chemico-Biol. Interactions, 138: 137-153.

Published Abstracts

Moufarij, M.A. (2009) Insights into cancer: advances and challenges. 8th Middle East Oncology Congress, Lebanon.

Moufarij, M.A., Keating, M.J. and Plunkett, W. (2008) Combination therapy in chronic Leukemia. American Association for Cancer Research, USA.

Moufarij, M.A., Keating, M.J. and Plunkett, W. (2005) Modulation of oxaliplatin cytotoxicity by fludarabine in chronic lymphocytic leukemia. American Association for Cancer Research, California, USA.

Moufarij, M.A., Sampath, D., Keating, M.J. and Plunkett, W. (2004) Potentiation of oxaliplatin cytotoxicity in chronic lymphocytic leukemia by nucleoside analogues. American Association for Cancer Research, Florida, USA.

Moufarij, M.A., Phillips, D.R., Haviv, I. and Cullinane, C. (2003) DNA Microarray applications to identify target genes which confer cisplatin resistance. 15th Lorne Cancer Conference, Lorne, Australia.

Moufarij, M.A. and Phillips, D.R. Gemcitabine potentiates cisplatin cytotoxicity. (2002) 14th Lorne Cancer Conference, Lorne, Australia

Moufarij, M.A., Phillips, D.R. and Cullinane, C. (2002) Role of DNA repair pathways in the synergistic interaction between gemcitabine and cisplatin. 37th Middle East Medical Assembly, Beirut, Lebanon. 

Moufarij, M.A. (2002 Mechanisms of drug interactions in combination chemotherapy, American University of Beirut, Beirut, Lebanon..

Moufarij, M.A. and Phillips, D.R. (2002) Inhibition of repair of cisplatin damage by gemcitabine in 2008 ovarian cancer cells. Research Trends in Science and Technology Conference, Beirut, Lebanon.

Moufarij, M.A., Phillips, D.R. and Cullinane, C. Inhibition of repair of cisplatin-induced DNA damage by gemcitabine. (2001) 13th Lorne Cancer Conference, Lorne, Australia.

Moufarij, M.A. and Phillips, D.R. (2001) Potentiation of cisplatin cytotoxicity by gemcitabine. 4th Peter Mac Symposium, Melbourne, Australia.